|
Bristol-Myers Squibb Foundation announces $6 million in grants
|
10 June 2012 |
|
ORENCIA® (abatacept) demonstrates comparable efficacy to Humira® (adalimumab)
|
06 June 2012 |
|
Bristol-Myers Squibb announces global collaboration with leading academic institutions
|
29 May 2012 |
|
Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India
|
15 May 2012 |
|
Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership
|
15 May 2012 |
|
Bristol-Myers Squibb delivers a solid first quarter
|
27 April 2012 |
|
Bristol-Myers Squibb and Duke Translational Medicine Institute form strategic relationship
|
29 February 2012 |
|
Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia
|
19 February 2012 |
|
Bristol-Myers Squibb Completes Acquisition of Inhibitex, Inc.
|
13 February 2012 |
|
Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex
|
08 February 2012 |
|
Bristol-Myers Squibb delivers solid fourth quarter capping a year highlighted by new product approvals
|
26 January 2012 |
|
Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million to Support Cancer Patients
|
19 January 2012 |
|
Bristol-Myers Squibb to Acquire Inhibitex
|
08 January 2012 |
|
Simcere and Bristol-Myers Squibb Enter Innovative Partnership
|
14 December 2011 |
|
Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals
|
04 December 2011 |
|
Bristol-Myers Squibb Foundation's Together on Diabetes® Initiative Marks First Anniversary
|
14 November 2011 |
|
ASLAN Pharmaceuticals and Bristol-Myers Squibb Enter Innovative Partnership
|
03 November 2011 |
|
Bristol-Myers Squibb Delivers Strong Third Quarter
|
28 October 2011 |
|
Bristol-Myers Squibb Announces Changes in Senior Management Team
|
20 October 2011 |
|
Bristol-Myers Squibb Foundation Announces Collaboration with World Health Organization's Stop TB Department
|
11 October 2011 |